Evaluation of Pyocyanin induced systemic pathogenicity of Pseudomonas aeruginosa

Muhammad Ibrahim Rashid1, Saadia Andleeb1, Amjad Ali1

  • 1Atta ur Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan.

Insights

Pseudomonas aeruginosa produces pyocyanin, a virulence factor found in cystic fibrosis patients. This study shows pyocyanin has harmful oral toxicity and causes oxidative stress in mouse organs, particularly the lungs and heart.

Area of Science:

  • Microbiology
  • Toxicology
  • Biochemistry

Background:

  • Pseudomonas aeruginosa (PA) is a significant nosocomial pathogen known for developing drug resistance.
  • Pyocyanin (PCN), a redox-active virulence factor produced by PA, is found in higher concentrations in cystic fibrosis patients' sputum.
  • Understanding PCN's toxicity is crucial for managing PA infections.

Purpose of the Study:

  • To characterize pyocyanin (PCN) produced by Pseudomonas aeruginosa.
  • To investigate the in silico and in vivo toxicity of PCN.
  • To assess the impact of PCN on oxidative stress in different organs.

Main Methods:

  • Isolation and characterization of PCN-producing PA strains.
  • Genomic sequencing of the 16s rRNA gene segment.
  • In silico analysis of PCN's absorption, binding, and permeability.
  • In silico oral toxicity assessment using a rodent model.
  • In vivo assessment of PCN-induced oxidative stress in balb/c mice.

Main Results:

  • In silico analysis predicted high intestinal absorption, plasma protein binding, and membrane permeability for PCN.
  • In silico oral toxicity studies classified PCN as 'harmful if swallowed' (Class IV, LD50 0.3-2g/kg).
  • In vivo studies showed significant alterations in oxidative stress levels in mouse organs, with increased levels in lungs and heart, and decreased levels in the liver and spleen.

Conclusions:

  • Pyocyanin exhibits significant toxicological properties, including harmful oral toxicity and the induction of oxidative stress.
  • The findings highlight PCN as a key virulence factor contributing to PA pathogenesis, particularly in the context of cystic fibrosis.
  • Further research into PCN's mechanisms of toxicity is warranted to develop targeted therapeutic strategies.